Does FOSCARNET Cause Hypervolaemia? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hypervolaemia have been filed in association with FOSCARNET (Foscarnet Sodium). This represents 0.3% of all adverse event reports for FOSCARNET.
6
Reports of Hypervolaemia with FOSCARNET
0.3%
of all FOSCARNET reports
4
Deaths
5
Hospitalizations
How Dangerous Is Hypervolaemia From FOSCARNET?
Of the 6 reports, 4 (66.7%) resulted in death, 5 (83.3%) required hospitalization.
Is Hypervolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSCARNET. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does FOSCARNET Cause?
Off label use (610)
Drug ineffective (368)
Drug resistance (309)
Acute kidney injury (246)
Cytomegalovirus infection (200)
Nephropathy toxic (198)
Pathogen resistance (190)
Renal impairment (184)
Pancytopenia (170)
Cytomegalovirus infection reactivation (167)
What Other Drugs Cause Hypervolaemia?
TREPROSTINIL (580)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (428)
AMBRISENTAN (205)
MACITENTAN (202)
FUROSEMIDE (139)
AMLODIPINE (122)
CYCLOPHOSPHAMIDE (118)
SACUBITRIL\VALSARTAN (115)
TACROLIMUS (100)
PREDNISONE (98)
Which FOSCARNET Alternatives Have Lower Hypervolaemia Risk?
FOSCARNET vs FOSFOMYCIN
FOSCARNET vs FOSFOMYCIN TROMETHAMINE
FOSCARNET vs FOSINOPRIL
FOSCARNET vs FOSPHENYTOIN
FOSCARNET vs FOSTAMATINIB